MolecuLight
Jordan J. has a diverse work experience in regulatory affairs, compliance, quality management, and teaching. They have held positions at various companies, including MolecuLight, Stryker, Fio Corporation, Southmedic Inc., and FCA Fiat Chrysler Automobiles. At MolecuLight, they served as the Director of Regulatory Affairs, Compliance & Quality. They also worked as a Regulatory Affairs Professor at the Regulatory Affairs Graduate Certification program starting in 2023. At Stryker, they held roles in regulatory affairs and regulatory/quality management. They were a Senior Regulatory Affairs Associate at Fio Corporation and worked as a Regulatory Affairs Specialist, Consultant, and Associate at Southmedic Inc. Additionally, Jordan J. worked as a Teaching Assistant at Peel District School Board and a Research Assistant at the University of Toronto.
Jordan J. completed an Honours BSc in Life Sciences at the University of Toronto from 2009 to 2013. Following this, Jordan pursued a Postgraduate Professional Studies program in Regulatory Affairs at Humber College from 2013 to 2014. From 2014 to 2018, Jordan attended Sheridan College where they obtained a degree in Project Management.
In 2018, Jordan furthered their education by obtaining a Master of Business Administration (MBA) from McMaster University. During the same year, they also received a certification as a Lean Six Sigma Green Belt from the Lean Six Sigma Council.
Within the field of auditing and certifications, Jordan earned a Team Lead Auditor Certificate from BSI in ISO 13485:2016 and ISO 9001:2015. Additionally, they obtained an ISO 9001:2015 Requirements Certificate from BSI in 2016. In 2015, Jordan completed a Lead Auditor Certificate from MBC in Canadian Medical Device Regulations.
Lastly, Jordan took part in a Topics in Developmental Neurobiology program at the University of Toronto in 2014, though it is unclear if there was a specific end date for this program.
This person is not in any teams
MolecuLight
Moleculight is developing a non-invasive optical technology that acquires images like standard point-and-shoot digital cameras. The device provides real-time bacteriological information which is otherwise unobtainable using industry-standard wound assessment techniques, including conventional white light visualization.The first application ofthis technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing a rapid and accurate diagnosis.